A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 412 participants.

Also called NCT02920593

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 412 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02920593
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02920593. Randomized; no masking; primary purpose prevention. Start 2016-10 (registry gives no type); primary completion 2018-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
Condition
Gestational Hypertension
Condition
Toxemia
Condition
Superimposed Preeclampsia
Condition
Eclampsia
Condition
HELLP Syndrome
Intervention (Drug)
Vitamin D3
Lead sponsor
Stony Brook University (class: other)

Record details

Record id
cardio:ct-nct02920593
Content hash
d3421343e31dd056a97eacc733f5b49c20be308a993dce93d133badf4da4995c